🇺🇸 FDA
Patent

US 9951353

Engineering neural stem cells using homologous recombination

granted A61KA61K35/30A61K48/00

Quick answer

US patent 9951353 (Engineering neural stem cells using homologous recombination) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K35/30, A61K48/00, A61P, A61P25/28